癌症中nectin-4的治疗前景:应用和价值
Kaiyue Li1, Yujing Zhou1, Maolin Zang2
1Department of Nuclear Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Frontiers in oncology
|April 12, 2024
概括
一种在癌症中过度表达的蛋白质Nectin-4是新的癌症疗法的一个有希望的目标. 目前正在进行研究,以了解其在瘤发生中的作用,并开发有效的治疗方法,如恩福图马布维多丁.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 尼克-4是一种细胞粘附分子,与健康组织相比,在各种恶性瘤中表达显著增加.
- 过度表达Nectin-4与乳腺癌,尿道癌和肺癌等癌症的发生和进展有关.
研究的目的:
- 审查nectin-4在瘤中的诊断潜力,预后意义和分子作用.
- 专注于Nectin-4向治疗,包括临床试验和针对恶性瘤的新药开发.
主要方法:
- 对瘤中Nectin-4表达研究的文献综述.
- 对Nectin-4向治疗的临床试验数据的分析.
- 对Nectin-4在瘤发生中的作用背后的分子机制的审查.
主要成果:
- 尼克-4是一种经过验证的治疗标,FDA批准了因福图马布维多丁治疗尿路癌的证据.
- 许多针对nectin-4的药物正在针对各种癌症进行临床试验,这表明其具有治疗潜力.
- 尼克-4在瘤发生和进展中的精确机制仍在研究中.
结论:
- 尼克-4作为诊断和预后生物标志物以及瘤学中的治疗点具有显著的前景.
- 对Nectin-4分子功能的进一步研究和克服药物耐药性等挑战对于推进向癌症治疗至关重要.
更多相关视频
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.0K
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
9.0K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
